Nefertiti Dupont, MD
Gynecologic Oncology · la Crosse, WINPI 1326105511
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $26,125 of the $35,981 with a category attached, or 72.6%. Sanara Medtech Inc. accounts for 78.5% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $14,455, 3.0 times the $4,795 reported in 2019. Among gynecologic oncology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 48 payments — averaging $749.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanara Medtech Inc.$28K
- Wound Management Technologies, Inc$4K
- GSK$2K
- Merck$412
- Mckesson Medical-surgical, Inc.$275
- AstraZeneca$180
- plus $641 from 8 others
What the payments were for
- Consulting fees$26,12573%
- Speaking & faculty fees$7,47521%
- Travel & lodging$9313%
- Food & beverage$1,4354%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanara Medtech Inc. | 12 | $28,262 |
| Wound Management Technologies, Inc | 3 | $4,135 |
| GSK | 3 | $2,075 |
| Merck | 12 | $412 |
| Mckesson Medical-surgical, Inc. | 1 | $275 |
| AstraZeneca | 2 | $180 |
| Tesaro, Inc. | 2 | $139 |
| Clovis Oncology, Inc. | 2 | $125 |
| Coopersurgical, Inc. | 1 | $112 |
| Myriad Genetic Laboratories, Inc. | 3 | $94 |
| Tempus AI, Inc | 3 | $72 |
| AbbVie | 2 | $46 |
| Johnson & Johnson | 1 | $31 |
| Eisai Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CellerateRx$32,306
- ZEJULA$125
- Rubraca$113
- Uterine Manipulators & Injectors$112
- LYNPARZA$109
- KEYTRUDA$105
How this compares
$35,981 in reported general payments places this provider in the 95th percentile of 30 gynecologic oncology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 53 | $3,106 |
| Gabapentin | 22 | $393 |
| Clobetasol Propionate | 11 | $355 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $110 |
| Fluconazole | 40 | $103 |
| Oxybutynin Chloride | 12 | $57 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in la Crosse
- Paul TsengWauwatosa$10K
- Lisa BarroilhetMadison$9K
- Scott KamelleWest Allis$6K
- Irina DimitrovaMilwaukee$4K
- William BradleyMilwaukee$3K
- Kristen StearnsMadison$2K
- Elizabeth Dickson MichelsonMilwaukee$2K
- Elizabeth DubilGreen Bay$1K
- Laura HuffmanMadison$1K
- Elizabeth FarabeeMadison$857
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.